Table 2. Summary of DKAT marker expression (MEGM/SCGM).
| DKAT line | ||
| Marker | MEGM media | SCGM media |
| ER | (−) | (−) |
| PR | (−) | (−) |
| HER2 | Not amplified | Not amplified |
| EGFR | (+) | (+) |
| CK5 | (++) | (−) |
| CK14 | (−) | (−) |
| CK17 | (++) | (+/−) |
| CK8 | (++) | (+/−) |
| CK18 | (++) | (+/−) |
| E-cadherin | ||
| membrane | (+) | (−) |
| cytoplasmic | (+) | (+) |
| vimentin | (+/−) | (+++) |
| p63 | (+) | (−) |
| snail-1 | (++) | (++) |
| snail-2/slug | (+) | (+) |
| claudin-1 | (+) | (−) |
| claudin-4 | (+) | (−) |
| occludin | (+) | (−) |
| Akt | (+) | (+) |
| pAkt-Ser473 | (+++) | (++) |
| PTEN | (−) | (+) |
| p53 | mutant | mutant |
| PI3K | wt | wt |
Qualitative evaluation based on immunofluorescence or western blot of DKAT cells grown in MEGM or following 14 days in SCGM media.